News

Biocon Biologics Expands Diabetes Portfolio With FDA Approval Of Kirstytm, The First And Only Interchangeable Rapid-Acting Insulin Aspart In The United States
BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL) , a fully int ...
moneycontrol.com10m
Stocks to Watch Today: Ashok Leyland, Dixon Tech, Zydus Lifesciences, ICICI Lombard, HDB Financial, HDFC Life, Jindal Steel, Biocon in focus on 16 July
Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and acquisitions, here’s a quick look at which stocks will be in focus in ...